Product news from the 08/22/06 News Brief
Oscient Pharmaceuticals has completed its acquisition of the US rights to the cardiovascular product Antara 130 mg (fenofibrate) capsules from ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.